High Cholesterol

Clinical Trial Finder

Many patients with high cholesterol are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

IN-TANDEM Familial Hypercholesterolemia Pilot Study

Condition:   Familial Hypercholesterolemia
Intervention:   Other: Genetic testing
Sponsors:   University of Pennsylvania;   The FH Foundation;   Lancaster General Hospital
Recruiting - verified August 2017

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Condition:   Homozygous Familial Hypercholesterolemia
Intervention:   Device: HDL Therapeutics PDS-2 System
Sponsors:   HDL Therapeutics;   MedStar Heart and Vascular Institute
Not yet recruiting - verified August 2017

Pediatric Preventative Health Screenings - Obesity and Family-Centered Outcomes

Conditions:   Obesity;   Overweight;   Blood Pressure;   Hypercholesteremia;   Diabetes
Intervention:   Behavioral: Motivational interviewing to elicit PCO in pediatrics
Sponsor:   Henry Ford Health System
Recruiting - verified August 2017

A Study in Subjects With Type 2 Diabetes Mellitus With Hypercholesterolemia/Mixed Dyslipidemia

Conditions:   Hypercholesterolemia;   Mixed Dyslipidemia;   Type 2 Diabetes
Interventions:   Biological: Evolocumab;   Other: Placebo to Evolocumab
Sponsor:   Amgen
Active, not recruiting - verified August 2017

Graves' Orbitopathy and Hypercholesterolemia

Conditions:   Graves' Ophthalmopathy;   Hypercholesterolemia
Intervention:   Other: No intervention
Sponsor:   University of Pisa
Completed - verified August 2017

Atorvastatin Effectiveness and Safety in Cardiology Patients in Real World Setting

Condition:   Coronary Artery Disease, Hypercholesterolemia, Hypertension
Intervention:   Other: No intervention
Sponsor:   Pfizer
Recruiting - verified August 2017

Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE)

Condition:   Hypercholesterolemia
Interventions:   Drug: ALIROCUMAB SAR236553 (REGN727);   Drug: placebo (for injection training only)
Sponsors:   Sanofi;   Regeneron Pharmaceuticals
Active, not recruiting - verified August 2017

Statins at the Primary Care Level

Condition:   Dyslipidemia
Intervention:   Other: Educational Intervention
Sponsor:   Institute for Clinical Effectiveness and Health Policy
Completed - verified August 2017

Glucose Metabolism Disorders and Metabolic Syndrome Before and After Primary Hip and Knee Replacement

Conditions:   Hyperglycemia;   Hypercholesterolemia;   Persistent Postoperative Pain;   Hip Replacement;   Knee Replacement
Intervention:  
Sponsors:   Coxa, Hospital for Joint Replacement;   University of Tampere;   Tampere University Hospital
Suspended - verified August 2017